ResMed gets US clearance for VPAP II:
This article was originally published in Clinica
Executive Summary
ResMed has received US FDA clearance to market its bilevel continuous positive airway pressure (CPAP) system, VPAP II ST. The system, which is already on sale outside the US, has both spontaneous and timed-mode features. ResMed's Autoset portable CPAP system received FDA clearance in July. The company, which is based in Sydney, Australia, floated on the Nasdaq in June 1995 (see Clinica No 662, p 14). About 20 million Americans suffer from sleep apnoea.